The BDNF val66met polymorphism is not associated with late onset Alzheimer's disease in three case–control samples
- 21 June 2005
- journal article
- Published by Springer Science and Business Media LLC in Molecular Psychiatry
- Vol. 10 (9), 809-810
- https://doi.org/10.1038/sj.mp.4001702
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Glutamate and acetylcholine corelease at developing synapsesProceedings of the National Academy of Sciences of the United States of America, 2004
- Brain-derived neurotrophic factor, apolipoprotein E genetic variants and cognitive performance in Alzheimer’s diseaseNeuroscience Letters, 2004
- Polymorphism at Codon 66 of the Brain-Derived Neurotrophic Factor Gene Is Not Associated with Sporadic Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2004
- Brain‐derived neurotrophic factor genetic variants are not susceptibility factors to Alzheimer's disease in ItalyAnnals of Neurology, 2004
- Association Analysis of Brain-Derived Neurotrophic Factor Val66Met Polymorphisms with Alzheimer’s Disease and Age of OnsetNeuropsychobiology, 2004
- The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal FunctionCell, 2003
- A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E ε4 alleleMolecular Psychiatry, 2002
- Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's diseaseMolecular Psychiatry, 2002
- A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's diseaseMolecular Psychiatry, 2000